Tactic Pharma LLC

Monopar Therapeutics Inc. · 10% Owner

Tactic Pharma LLC is listed in public filings as 10 percent owner. This Tactic Pharma LLC insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Monopar Therapeutics Inc. (MNPR). Investors use Tactic Pharma LLC's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Monopar Therapeutics Inc.MNPR$35M550.2k sharesSellSep 24, 2025$63.61--